Clinical Trials Directory

Trials / Completed

CompletedNCT01845519

Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors

Feasibility of a Technology-based Intervention to Reach Inactive Breast Cancer Survivors and Objectively Track Step Activity.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Leanne Kaye · Academic / Other
Sex
Female
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study aims to recruit post-treatment breast cancer survivors for a 12-week 2-arm randomized walking intervention. All intervention materials will be delivered electronically. The investigators hypothesize that at the end of 12-weeks, participants randomized to the intervention group will engage in more weekly steps than those participants randomized to the comparison group.

Detailed description

More than two-thirds of breast cancer survivors are physically inactive. Inactivity is known to negatively impact both morbidity and mortality, and is especially pronounced among cancer survivors. Self-directed interventions targeting inactivity among breast cancer survivors often report clinically insignificant behavior change. More successful behavior change interventions have suggested that tailoring and, more recently, the fostering of intrinsic motivation, may have improved outcomes. However, no interventions to date have utilized these approaches to increase physical activity among sedentary cancer survivors. AIM 1: Develop and test intervention (tailored) and comparison group (targeted) messages in a sample of sedentary women to determine message acceptability. AIM 2: Determine the efficacy of a 12-week tailored intervention to increase the number of weekly steps taken among sedentary post-treatment breast cancer survivors compared to a 12-week, targeted intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTailored EmailParticipants will receive tailored emails.
BEHAVIORALTargeted EmailParticipants will receive targeted emails.

Timeline

Start date
2013-07-01
Primary completion
2014-04-01
Completion
2014-06-01
First posted
2013-05-03
Last updated
2015-06-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01845519. Inclusion in this directory is not an endorsement.